Palliser Capital (UK) Ltd / TBPH
Palliser Capital (UK) Ltd’s Theravance Biopharma Inc Position
Does Palliser Capital (UK) Ltd own Theravance Biopharma Inc (TBPH)? Not currently — the last reported position was 97.1K shares worth $1M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q4 2022
Shares
97.1K
% of Portfolio
+2.65%
Quarters Held
1
position exited
Position History TBPH
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 97.1K | $1M | +2.65% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palliser Capital (UK) Ltd’s full portfolio or all institutional holders of TBPH.